It’s in the news! Got a few minutes? Get caught up! Top stories this week: Dexcom is reportedly in talks to buy Omnipod, Abbott & Dexcom sue and countersue each other over patents, new study showing people with type 1 diabetes are living longer, a JDRF advocate climbs Mt Everest, and more! Check out Stacey’s…
Mike Joyce is out there – somewhere – on the Pacific Crest Trail. He set out a couple of days before this episode airs, on a 2600 mile long distance hike. It’s part of his attempt to complete what’s called the Triple Crown of Hiking. He’s already done the Appalachian Trail and the Continental Divide…
It’s in the news! Got a few minutes? Get caught up! Top stories this week: new research that keeps beta cells safer after transplant, a new drug for type 2 also shows weight loss success, the makers of Afrezza buy a simple patch pump, Beyond Type 1 tackles mental health and diabetes and lots more!…
We’ve got an update from Beta Bionics, makers of the iLet pump. This is the system that, among many other things, requires very little input from the user. They’re hoping this makes it accessible for more people. Stacey talks to to interim CEO Martha Goldberg Aronson. She shares more information about recent studies regarding the Ilet,…
It’s “In the News…” Got a few minutes? Get caught up! Top stories this week: racial disparities in treatment for kids with type 1, new study looks at oral insulin for type 2, nanoparticles tested to prevent diabetes and why is there a Squishmallow toy being marketed as having T1D? That and a lot more.…
Dexcom’s G7 is in front of the FDA right now. There are some significant changes to the system, including what’s basically a snooze for essential alarms, including the urgent low. Dexcom’s Chief Technology Officer Jake Leach answers your questions about adhesive, direct to watch, accuracy, and even mentions the G8. Here’s more information about the…
It’s “In the News…” Got a few minutes? Get caught up! Top stories this week: An FDA hiccup for Vertex, Omnipod 5 starts wider rollout, New peek at Dexcom G7 features, Beta Bionic study info, “Hey Alexa, predict my blood sugar” and Healthline shuts down their main source of diabetes news and information. — Join…
This week, we’re having a conversation about diabetes beyond numbers. Yes, there are a lot of those and they are very important. But have you ever stopped to think about the mental energy and emotional effort behind those numbers? Even if your A1C and Time in Range are what your doctor wants to see. Our…
It’s “In the News…” Got a few minutes? Get caught up! Our top stories this week include headlines from the ATTD Conference – that’s the Advanced Technologies and Treatments for Diabetes Conference. There’s a bit of new information about the Dexcom G7, Beta Bionics announces it will release pivotal trial results, and news of the…
Could this finally be a big shake up in the price of insulin? Civica Rx plans to sell the most popular types of fast and long acting insulin for a flat price of 30-dollars a vial. This week you’ll hear from Ned McCoy, Civica’s Chief Operating Officer. He explains why they’re confident this will work,…